Table 5.
Comparison of the data of the 4 improved patients to those who did not improve
| Parameter | Mean | SD | T | P value | CI Lower | CI Upper | |
|---|---|---|---|---|---|---|---|
| BMI | No response | 37.19 | 6.649 | ||||
| Improved steatosis | 33.27 | 1.12 | 4.41 | ≤ 0.01 | 2.04 | 5.78 | |
| Waist | No response | 114.87 | 12.19 | ||||
| Improved steatosis | 106.5 | 4.43 | 3.28 | ≤ 0.01 | 1.9 | 14.84 | |
| Hip | No response | 117.13 | 11.7 | ||||
| Improved steatosis | 112.5 | 1.0 | 3.55 | ≤ 0.01 | 2.03 | 7.24 | |
| BSF | No response | 0.45 | 0.12 | ||||
| Improved steatosis | 0.32 | 0.05 | 4.62 | ≤ 0.01 | 0.05 | 0.2 | |
| ALT | No response | 36.92 | 20.51 | ||||
| Improved steatosis | 27.52 | 3.69 | 3.34 | ≤ 0.01 | 3.41 | 15.38 | |
| AST | No response | 38.8 | 19.97 | ||||
| Improved steatosis | 30.75 | 3.45 | 2.99 | ≤ 0.01 | 2.37 | 13.73 | |
| APRI | No response | 0.61 | 0.336 | ||||
| Improved steatosis | 0.5 | 0.068 | 2.4 | ≤ 0.01 | 0.01 | 0.22 | |
BMI – body mass index, BSF – biceps skin fold, ALT – alanine transaminase, AST – aspartate transaminase